Edward J. Bastyr

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes

Juan P. Frías, Edward J. Bastyr, Louis Vignati et al. · Cell Metabolism · 2017 · 321 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

Edward J. Bastyr, CA Stuart, Robert G. Brodows et al. · Diabetes Care · 2000 · 275 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

The Development and Validation of the Norfolk QOL-DN, a New Measure of Patients' Perception of the Effects of Diabetes and Diabetic Neuropathy

Etta J. Vinik, Risa P. Hayes, Alan Oglesby et al. · Diabetes Technology & Therapeutics · 2005 · 238 citations

Medicine, Neurology, Diabetology +15

Metabolic and immunologic effects of insulin lispro in gestational diabetes.

Lois Jovanovič, Sanja Ilic, D J Pettitt et al. · Diabetes Care · 1999 · 237 citations

Medicine, Endocrinology, Maternal Health +17

Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy

Edward J. Bastyr, Karen Price, Vera Bril · Clinical Therapeutics · 2005 · 199 citations

Medicine, Neurology, Diabetology +16